Regentis Biomaterials RGNT
NYSE RGNT
$1.83 +0.01 (+0.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regentis Biomaterials (RGNT) Other Accumulated Expenses (2025 - 2026)

Updated

Regentis Biomaterials' Other Accumulated Expenses came in at $499,000 for Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Other Accumulated Expenses (2025 - 2026) Analysis & Trends

At the end of FY2025, Regentis Biomaterials' Other Accumulated Expenses was $1.2 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Regentis Biomaterials 1.04 Mn -7.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 499,000.00
Dec 31, 2025 1.20 Mn
API Access

Regentis Biomaterials Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RGNT&period=max&api_key=YOUR_API_KEY